Publikationen

Auswahl

Links zu ausgewählten Publikationen (open access):

Langlitz et al. 2024: Neuroethics Psychedelic Therapy

Aicher et al. 2024: Psychedelika Psychotherapie Schweiz

Wolfson et al. 2024: Ketamin Psychotherapy

Barksdale et al. 2024: Neurobiology Psychedelics

Aaronson et al. 2023: Psilocybin Bipolar II

Nardou et al. 2023 (Nature): Psychedelic Social reward mouse model

Raison et al. 2023: Depression Psilocybin

Mitchell et al. 2023 (Nature Medicine): PTSD MDMA

Walsh et al. 2023: Depression LSD society use

Knatz et al. 2023 (Nature Medicine): Anorexia Psilocybin

Calder et al. 2023: Psychedelic safety

Volkow et al. 2023: Psychedelic opinion

Simonsson et al. 2023: Psilocybin depression risk

Evens et al. 2023: Psychedelic afterglow …

Mash 2023: Ibogaine

Buoso et al. 2023: Adverse effects of Ayahuasca …

Ryan et al. 2023: Experience of microdosing psychedelics …

Ponomarenko et al. 2023: Can psychedelics enhance group psychotherapy?

von Rotz et al. 2023: Single-dose psilocybin-assisted therapy in major depressive disorder …

Carhart-Harris 2023: Translational Challenges in Psychedelic Medicine

Murphy et al. 2022: Therapeutic Alliance and Rapport Modulate Responses to Psilocybin …

Brody 2022: Psychedelic medicine (Nature outlook)

Irizarry et al. 2022: Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis

Gukasyan et al. 2022: Efficacy and safety of psilocybin-assisted treatment for major …

Oehen & Gasser 2022: Using a MDMA- and LSD-Group Therapy Model in Clinical …

Fusar-Poli & Borgwardt 2019: Albert Hofmann the Father of LSD

Nutt & Carhart-Harris 2020: Psychedelic Psychiatries brave new world

Reiff et al. 2020: Psychedelics and Psychedelic assisted Psychotherapy

Davis et al. 2020: Effects of Psilocybin-Assisted Therapy on Major Depressive …

Bogenschutz et al. 2022: Percentage of heavy drinking days following Psilocybin-…

Goodwin et al. 2022: Single-Dose Psilocybin for a Treatment-Resistant Episode …

Müller et al. 2020: Hallucinogens and Entactogens – establishing a new class of …

Holze et al. 2019: Distinct acute effects of LSD, MDMA and D-amphetamine

Daws et al. 2022: Increased global integration in the brain after psilocybin …

McCulloch et al. 2022: Psychedelic resting-state neuroimaging: A review …

Girn et al. 2022: Serotonergic psychedelic drugs LSD and psilocybin reduce …

Schlag et al. 2022: Adverse effects of psychedelics: From anecdotes and misinf. …

Price et al. 2022: A Novel, Brief, Fully Automated Intervention to Extend the Antidepressant …